Implementing Artificial Intelligence (AI) to Prevent Vision Loss From Diabetes
Sponsor: University of Wisconsin, Madison
Trial Details
| Condition | Vision Disorders, Diabetes |
| Intervention | AI; Usual Practice |
| Phase | NA |
| Status | Unknown |
| Participants | 1,700 |
| Est. Completion | 1 Feb 2027 |
| Last Updated | 30 Apr 2026 |
Primary Outcome
Proportion of patients who get eye screening in the AI and usual-care arms within 5 months of the recommendation
Eligibility Criteria
Inclusion Criteria
Clinic Inclusion Criteria: * Serve at least 267 patients with diabetes during the study period * No point-of-care screening system in use for diabetic eye disease * Agree to share limited identifiers data as requested Patient Inclusion Criteria: * Age 22 years or older * Diagnosis of type 1 or 2 diabetes * No known diabetic eye disease * No diabetic eye exam in the past 12 months Exclusion Criteria: * Have a documented eye exam in the electronic health record within 12 months of the date of the primary care visit. * Contraindication includes diagnosed with macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy, or retinal vein occlusion. * Pregnant
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service